wire - news in brief




Page not found (Error 404)




Environment - Mar 26
Environment
Tropical storms that move poleward influence the weather in Europe much more than previously supposed. A study from the Mobiliar Lab for Natural Risks at the University of Bern shows that the probability of heavy rainfall is twice as high when mid-latitude weather is disrupted by cyclones. These findings could ensure better extreme weather forecasts in the future.
Life Sciences - Mar 26
Life Sciences

UNIGE researchers demonstrate that maternal and environmental control of seed dormancy is carried out through novel epigenetic mechanisms.

Life Sciences - Mar 26
Life Sciences

Scientists from EPFL, UNIL and local startup be.care have developed a system that uses heart rate variability to detect fatigue and identify what kind it is.


Category



Results 1 - 50 of 351.
1 2 3 4 5 8 Next »


Pharmacology - Health - 27.03.2019
Novartis receives FDA approval for Mayzent (siponimod), the first oral drug to treat secondary progressive MS with active disease
Mayzent (siponimod) is the first and only treatment specifically approved for patients with active secondary progressive multiple sclerosis (SPMS) in over 15 years   Up to 80% of patients with relaps

Environment - 26.03.2019
Gaps in the law cause pollution
Gaps in the law cause pollution
Diesel vans are dirtier in winter than many know: Where there are still gaps in emissions legislation, soot particles and nitrogen oxides (NOx) continue to be produced.

Life Sciences - Agronomy / Food Science - 25.03.2019
Corinne Boss Takes Reins of ’Animals and Products of Animal Origin’ Competence Division at Agroscope
Corinne Boss is the new Head of Agroscope's 'Animals and Products of Animal Origin' Competence Division for Research Technology and Knowledge Transfer; in this capacity, she also becomes a Member of the Agroscope Executive Board. A biologist and official expert in animal health, Corinne Boss currently works at the Swiss Federal Office for Agriculture (FOAG) as a Research Scientist in the 'Products of Animal Origin and Livestock Breeding' Division.

Environment - Social Sciences - 22.03.2019
World Water Day: What access to clean water really means
World Water Day: What access to clean water really means
Today's Unesco World Water Day has the theme "Leave no one behind". Many people still do not have access to safe water and sanitary facilities for various reasons.

Media - 22.03.2019
Official comment on recent media coverage
ETH Zurich provides an official comment on articles published recently in the online magazine Republik.

Business / Economics - 22.03.2019

Astronomy / Space Science - Materials Science - 20.03.2019
Mercury bound
Mercury bound
Another European Space Agency (ESA) satellite was launched last October: BepiColombo who is heading for Mercury - with Empa technology on board.

Computer Science / Telecom - 20.03.2019
Researchers flag global hardware security vulnerability
Researchers have identified a widespread computer security vulnerability affecting laptop, desktop and server hardware. Last year, the so-called Spectre and Meltdown security vulnerabilities made headlines when it was discovered that they affect the Intel central processing units (CPUs) in most laptop and desktop computers and servers.

Computer Science / Telecom - Business / Economics - 19.03.2019

Computer Science / Telecom - Business / Economics - 19.03.2019

Environment - Politics - 19.03.2019
Center to protect the Red Sea ecosystem
Center to protect the Red Sea ecosystem
Federal Councillor Ignazio Cassis, Head of the Federal Department of Foreign Affairs (FDFA), announced on Tuesday Switzerland's support for EPFL's project to create a "Transnational Red Sea Research Center".

Pharmacology - Health - 19.03.2019
FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer
Tecentriq in combination with chemotherapy (carboplatin and etoposide) is the first and only cancer immunotherapy approved for the initial treatment of extensive-stage small cell lung cancer (ES-SCLC

Innovation / Technology - Event - 18.03.2019

Business / Economics - Health - 18.03.2019

Transport - Environment - 15.03.2019
Cable cars could reshape urban landscapes
Cable cars could reshape urban landscapes
For his thesis at EPFL, Fernando Simas studied how cable cars could be an appealing transportation option for city commuters, and how they could be incorporated into tomorrow's urban landscapes.

Life Sciences - 15.03.2019
Female roundworms produce clones of themselves
Female roundworms produce clones of themselves
In the Mesorhabditis belari roundworm, the sole purpose of males is to help females produce clones of themselves. This unique form of reproduction was recently described by an international research team with participation of Peter Meister from the Institute of Cell Biology of the University of Bern.

Business / Economics - 15.03.2019
New SNSF Sinergia Research Consortium: The Swiss Elites Observatory recruits !
The Universities of Lausanne, Fribourg and Zurich launch in September 2019 a new ‘Sinergia' research consortium entitled ‘Local power structures and transnational connections.

Business / Economics - 15.03.2019
EPFL encourages its researchers to publish in open-access journals
EPFL has adopted an Open Access Policy clearly setting out its position on open access to EPFL publications.

Pharmacology - Health - 15.03.2019
European Commission approves Roche’s MabThera (rituximab) for a rare autoimmune disease
MabThera is the first biologic treatment approved for moderate to severe cases of the rare autoimmune disease pemphigus vulgaris (PV), and the first major advancement in the treatment of the disease

Health - Pharmacology - 14.03.2019
Novartis joins the Global Chagas Disease Coalition and also announces first multinational, prospective, randomized study in people with chronic Chagas cardiomyopathy
Study is planned to assess efficacy and safety of Entresto (sacubitril / valsartan) vs enalapril in 900 patients with chronic Chagas cardiomyopathy; recruitment is planned to commence within 2019   C

Astronomy / Space Science - Materials Science - 14.03.2019
Bernese Mars camera CaSSIS returns spectacular images
Three years ago, on 14 March 2016, the Bernese Mars camera CaSSIS started its journey to Mars with the "ExoMars Trace Gas Orbiter" spacecraft.

Careers / Employment - 14.03.2019

Pharmacology - 14.03.2019
Drug use in Swiss cities unchanged
Drug use in Swiss cities unchanged
In a large-scale, Europe-wide drug monitoring project, the wastewater of around 38 million people in 85 cities was analysed in the spring.

Business / Economics - 14.03.2019

Pharmacology - Health - 14.03.2019
European Commission approves Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors
First medicine to significantly reduce treated bleeds compared to prior factor VIII prophylaxis, in a prospective intra-patient comparison Only prophylactic medicine that can be given subcutaneously

Life Sciences - Psychology - 13.03.2019
New Marie Curie and EMBO Fellows at the FMI
Five of our postdocs were recently awarded the prestigious EMBO and Maria Sklodowska-Curie Actions (MSCA) Fellowships.

Transport - Innovation / Technology - 12.03.2019
The future of mobility is diverse
The future of mobility is diverse
Empa is presenting sustainable fuels of the future at the Petroleum Association's stand in Hall 6 of the Geneva Motor Show.

Innovation / Technology - Transport - 12.03.2019
The future of mobility is manifold
The future of mobility is manifold
Empa is presenting sustainable fuels of the future at the Petroleum Association's stand in Hall 6 of the Geneva Motor Show.

Health - Life Sciences - 12.03.2019
EPFL software mines rich medical data while keeping it secure
MedCo , developed in the lab of EPFL professor Jean-Pierre Hubaux in collaboration with professor Bryan Ford 's DEDIS lab and the Lausanne University Hospital ( CHUV ), is the first operational system to protect sensitive patient data - including genetic information - so that it can be used collectively for crucial medical research.

Environment - Innovation / Technology - 11.03.2019
Tove Larsen explains the toilet revolution
Tove Larsen explains the toilet revolution
The latest urine-diverting toilet is being "officially" presented today at the ISH sanitation trade fair in Frankfurt.

Environment - Physics - 11.03.2019
Turning buildings into energy producers
Turning buildings into energy producers
EPFL has become the coordinator of Be-Smart, an EU research project that aims to step up the deployment of building-integrated photovoltaics (BIPV) and cut their costs by 75% between now and 2030.

Life Sciences - 11.03.2019

Pharmacology - Health - 11.03.2019
FDA grants Roche’s Tecentriq in combination with Abraxane accelerated approval for people with PD-L1-positive, metastatic triple-negative breast cancer
This Tecentriq combination is the first cancer immunotherapy regimen approved for breast cancer Triple-negative breast cancer is an aggressive disease, with high unmet medical need Roche today announ

Health - Pharmacology - 11.03.2019
Roche’s VENTANA PD-L1 (SP142) Assay approved as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq in combination with Abraxane
PD-L1 (SP142) was the enrollment assay used in the IMpassion130 trial, the first positive phase III immunotherapy regimen study in triple-negative breast cancer Each year about 300,000 women are diag

Event - Innovation / Technology - 08.03.2019

Pharmacology - Health - 08.03.2019
European Commission approves Roche’s Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer
Approval based on significant survival benefit of Tecentriq in combination with Avastin, paclitaxel and carboplatin (chemotherapy) in people with metastatic non-squamous non-small cell lung cancer (N

Health - Pharmacology - 07.03.2019
Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash
Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in cash Roche today announced that it has commenced a cash tender offer for all of the outstanding shares of common stock of Spark Therapeutics, Inc.

Pharmacology - Health - 07.03.2019
Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untreated chronic lymphocytic leukaemia with co-existing medical conditions
Application is being reviewed under FDA's Real-Time Oncology Review pilot programme Combination was granted Breakthrough Therapy Designation, the fifth for Venclexta Roche today announced the submiss
1 2 3 4 5 8 Next »